M
Mohsen Ebrahimi
Researcher at Golestan University
Publications - 12
Citations - 131
Mohsen Ebrahimi is an academic researcher from Golestan University. The author has contributed to research in topics: Pharmacophore & Virtual screening. The author has an hindex of 3, co-authored 12 publications receiving 42 citations.
Papers
More filters
Journal ArticleDOI
Ultrasound wave assisted removal of Ceftriaxone sodium in aqueous media with novel nano composite g-C3N4/MWCNT/Bi2WO6 based on CCD-RSM model.
Xiaolong Shi,Aida Karachi,Mojgan Hosseini,Masoud Safari Yazd,Hesam Kamyab,Hesam Kamyab,Mohsen Ebrahimi,Zohreh Parsaee +7 more
TL;DR: The Langmuir isotherm equation fits the experimental data best and the removal followed pseudo-second order kinetics and the experimentally obtained maximum adsorption capacities was 19.57 mg.
Journal ArticleDOI
miRNAs; a novel strategy for the treatment of COVID-19.
TL;DR: In this article, the authors provided a summary of the current clinical application of miRNAs for the treatments of patients with COVID-19, and showed that host miRNs play an antiviral role and improve the treatment of patients.
Journal ArticleDOI
Differentiation of human induced pluripotent stem cells into erythroid cells
Mohsen Ebrahimi,Mehdi Forouzesh,Setareh Raoufi,Mohammad Ramazii,Farhoodeh Ghaedrahmati,Maryam Farzaneh +5 more
TL;DR: The in vitro production of human iPSC-derived RBCs can be an alternative treatment option for patients with blood disorders and an overview of the current status and applications of this field is presented.
Journal ArticleDOI
Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery
TL;DR: In this article, the potential for druggability of spike protein for pharmacophore-based drug discovery and to investigate the binding affinity of natural products with SARS-CoV-2 spike protein was examined.
Journal ArticleDOI
Susceptibility of the Iranian population to severe acute respiratory syndrome coronavirus 2 infection based on variants of angiotensin I converting enzyme 2
Alireza Mohebbi,Fatemeh Sana Askari,Mohsen Ebrahimi,Mana Zakeri,Mohammad Yasaghi,Hanieh Bagheri,Naeme Javid +6 more
TL;DR: The V485L variant of ACE2 could be a natural resistance mutation among the Iranian population and increase slightly the susceptibility to infection with the virus.